-
Kodak’s top exec sees $200 million windfall on stock frenzy
The net worth of Kodak’s top executive has skyrocketed on the company’s transformation from an ailing camera maker to cutting-edge pharmaceutical start-up — thanks in part to some timely share purchases. James Continenza, Kodak’s executive chairman and de facto CEO, was sitting pretty as the company’s largest individual shareholder — with 650,000 shares — when it emerged on Tuesday that Kodak would be launching a new pharmaceutical arm with help from the Trump administration. News of the $765 million loan — the first of its kind to reduce the US’s reliance on foreign manufacturers — sent Wall ... (full story)